{"schema_version":"secwatch.filing_event.v1","accession":"0000929638-26-001834","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2026-05-13T20:05:35+00:00","discovered_at":"2026-05-13T20:07:00.323726+00:00","generated_at":"2026-05-13T22:09:55.436213+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Q1 rev $8.9M (+2%); net loss $5.1M; DrugSorb-ATR FDA submission delayed to late 2026/early 2027","bullets":["Revenue $8.9M, +2% YoY; gross margin 69% vs 71% in Q1 2025.","Net loss $5.1M ($0.08/share) vs $1.5M ($0.02) in Q1 2025, driven by non-cash FX; adjusted net loss improved to $3.4M ($0.05).","Cash $6.4M vs $7.8M Dec 31; cash burn $1.1M (excl. $0.3M restructuring); targeting operating cash flow breakeven H2 2026.","DrugSorb-ATR for Brilinta: new De Novo submission delayed to late 2026/early 2027 after FDA requested additional mechanistic data.","Distributor orders delayed ~$500k in Middle East due to U.S.-Iran war; Germany direct sales slightly down but with smaller team."],"urls":{"canonical":"https://secwatch.observer/filing/0000929638-26-001834","json":"https://secwatch.observer/filing/0000929638-26-001834.json","markdown":"https://secwatch.observer/filing/0000929638-26-001834.md","text":"https://secwatch.observer/filing/0000929638-26-001834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000092963826001834/0000929638-26-001834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000092963826001834/a8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T22:09:55.436213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}